Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Umesh S. Shaligram"'
Autor:
Mariette Barbier, Katherine S. Lee, Mayur S. Vikharankar, Shriram N. Rajpathak, Nandkumar Kadam, Ting Y. Wong, Brynnan P. Russ, Holly A. Cyphert, Olivia A. Miller, Nathaniel A. Rader, Melissa Cooper, Jason Kang, Emel Sen-Kilic, Zeriel Y. Wong, Michael T. Winters, Justin R. Bevere, Ivan Martinez, Rachayya Devarumath, Umesh S. Shaligram, F. Heath Damron
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Emergence of variants of concern (VOC) during the COVID-19 pandemic has contributed to the decreased efficacy of therapeutic monoclonal antibody treatments for severe cases of SARS-CoV-2 infection. In addition, the cost of creating these therapeutic
Externí odkaz:
https://doaj.org/article/0dfd351321ae4d6fb831ca5d8efa7b16
Autor:
Sergio A. Rodriguez-Aponte, Neil C. Dalvie, Ting Y. Wong, Ryan S. Johnston, Christopher A. Naranjo, Sakshi Bajoria, Ozan S. Kumru, Kawaljit Kaur, Brynnan P. Russ, Katherine S. Lee, Holly A. Cyphert, Mariette Barbier, Harish D. Rao, Meghraj P. Rajurkar, Rakesh R. Lothe, Umesh S. Shaligram, Saurabh Batwal, Rahul Chandrasekaran, Gaurav Nagar, Harry Kleanthous, Sumi Biswas, Justin R. Bevere, Sangeeta B. Joshi, David B. Volkin, F. Heath Damron, J. Christopher Love
There is a continued need for sarbecovirus vaccines that can be manufactured and distributed in low- and middle-income countries (LMICs). Subunit protein vaccines are manufactured at large scales at low costs, have less stringent temperature requirem
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1ccf32630a7ae84f2a75bcce081265e
https://doi.org/10.1101/2022.09.14.507842
https://doi.org/10.1101/2022.09.14.507842
Autor:
Neil C. Dalvie, Lisa H. Tostanoski, Sergio A. Rodriguez-Aponte, Kawaljit Kaur, Sakshi Bajoria, Ozan S. Kumru, Amanda J. Martinot, Abishek Chandrashekar, Katherine McMahan, Noe B. Mercado, Jingyou Yu, Aiquan Chang, Victoria M. Giffin, Felix Nampanya, Shivani Patel, Lesley Bowman, Christopher A. Naranjo, Dongsoo Yun, Zach Flinchbaugh, Laurent Pessaint, Renita Brown, Jason Velasco, Elyse Teow, Anthony Cook, Hanne Andersen, Mark G. Lewis, Danielle L. Camp, Judith Maxwell Silverman, Gaurav S. Nagar, Harish D. Rao, Rakesh R. Lothe, Rahul Chandrasekharan, Meghraj P. Rajurkar, Umesh S. Shaligram, Harry Kleanthous, Sangeeta B. Joshi, David B. Volkin, Sumi Biswas, J. Christopher Love, Dan H. Barouch
Publikováno v:
Science advances. 8(11)
Authorized vaccines against SARS-CoV-2 remain less available in low- and middle-income countries due to insufficient supply, high costs, and storage requirements. Global immunity could still benefit from new vaccines using widely available, safe adju
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7367efa4509ffd185820d27cb76c03b2
https://pubmed.ncbi.nlm.nih.gov/35294244
https://pubmed.ncbi.nlm.nih.gov/35294244
Autor:
Neil C, Dalvie, Andrew M, Biedermann, Sergio A, Rodriguez-Aponte, Christopher A, Naranjo, Harish D, Rao, Meghraj P, Rajurkar, Rakesh R, Lothe, Umesh S, Shaligram, Ryan S, Johnston, Laura E, Crowell, Seraphin, Castelino, Mary Kate, Tracey, Charles A, Whittaker, J Christopher, Love
Publikováno v:
Biotechnology and Bioengineering
Prevention of COVID‐19 on a global scale will require the continued development of high‐volume, low‐cost platforms for the manufacturing of vaccines to supply ongoing demand. Vaccine candidates based on recombinant protein subunits remain impor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e13ddee7f526f0dd15890f8f18331d0c
https://pubmed.ncbi.nlm.nih.gov/34780057
https://pubmed.ncbi.nlm.nih.gov/34780057